News

Marker Therapeutics Showcases MAR-T Cell Innovations in Webcast

Marker Therapeutics Showcases MAR-T Cell Innovations in Webcast

Marker Therapeutics Highlights MAR-T Cell Innovations

Marker Therapeutics, Inc. (NASDAQ: MRKR), a clinical-stage immuno-oncology firm, is making waves in the field of T cell therapy. The company's Chief Executive Officer, Dr. Juan Vera, will be prominently featured in a virtual event titled "Seven Years After FDA Approval – Have CD19 CAR-T Cells Met Expectations?" This event, conducted by Demy-Colton in collaboration with the WBB Research Institute, takes place on May 28, 2025, at 11:00 a.m. EDT.

Insights into CAR-T Cell Therapies

The upcoming one-hour event is set to shed light on the advancements in CAR-T cell therapies. Industry experts will gather to discuss the evolution, challenges, and future potential of these therapies. Dr. Vera will present Marker’s innovative MAR-T cell therapy platform, designed to enhance effectiveness while addressing previous limitations associated with traditional CAR-T therapies.

Panel of Experts

Joining Dr. Vera are several esteemed panelists, recognized for their significant contributions to immuno-oncology:

  • Dr. Helen Heslop: Professor at Baylor College of Medicine, actively involved in cell and gene therapy.
  • Dr. Malcolm Brenner: Founding Director at Baylor College of Medicine and a key figure in cell and gene therapy research.
  • Dr. Manali Kamdar: Associate Professor at the University of Colorado, renowned for her work in oncology.
  • Dr. Geoffrey Shouse: Assistant Professor at City of Hope, contributing significantly to cancer research.
  • Dr. Juan Vera: President and CEO of Marker Therapeutics.
This esteemed team promises to deliver profound discussions responsive to pressing issues in cancer treatment.

Virtual Webcast Agenda

The agenda for the May 28 virtual webcast is structured as follows, fostering a comprehensive dialogue on CAR-T cell therapies:

  • 11:00 – 11:05 am: Opening remarks by Sara Demy, CEO of Demy-Colton, and Steve Brozak, President and Co-founder of WBB Securities.
  • 11:05 – 11:10 am: Dr. Helen Heslop discusses the shortcomings of CAR-T therapy.
  • 11:10 – 11:15 am: Dr. Malcolm Brenner gives insights on overcoming current limitations.
  • 11:15 – 11:20 am: Dr. Vera presents MAR-T cells as a new solution to unmet needs.
  • 11:20 – 11:50 am: An engaging roundtable discussion moderated by Dr. Richard Marfuggi, Medical Director of WBB Research Institute, featuring extensive dialogue among the expert panelists.
  • 11:50 – 12:00 pm: Q&A session, inviting audience interaction.

This roundtable is expected to be accessible globally, encouraging widespread participation and fostering critical discussions necessary for advancing treatment in the oncology field.

About Marker Therapeutics, Inc.

Founded at Baylor College of Medicine, Marker Therapeutics is based in Houston, Texas, and specializes in developing next-generation T cell therapies aimed at treating both hematological malignancies and solid tumors. The company has seen positive responses in clinical trials with over 200 patients, showcasing the potential of its autologous and allogeneic MAR-T cell therapies.

With a mission to enhance patient outcomes, Marker Therapeutics prioritizes operational excellence while securing funding from state and federal grant programs dedicated to cancer research. Their efforts in the field continue to gain momentum, promising innovations that could change the landscape of cancer treatment.

Frequently Asked Questions

What is the purpose of the upcoming webcast?

The webcast aims to address the current state and future possibilities of CAR-T cell therapies, featuring insights from leading experts.

Who will be participating in the expert panel?

Key opinion leaders in the field, such as Dr. Helen Heslop, Dr. Malcolm Brenner, Dr. Manali Kamdar, and Dr. Geoffrey Shouse will join Dr. Juan Vera in the discussion.

How does the MAR-T cell therapy differ from traditional CAR-T therapies?

MAR-T cell therapy employs a unique multi-antigen approach that aims to mitigate challenges faced by conventional CAR-T therapies.

How can participants join the discussion during the webcast?

Participants are encouraged to register in advance to actively engage in the roundtable discussions during the event.

What are the expected outcomes of the discussion?

The discussion aims to yield vital insights into current challenges in cancer treatment and potential advancements that can benefit patient care.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Mace Consult Bets on Sawaya for Americas Expansion

Updated Category News Views 120

Concrete, tunnel bores, and data-center campuses rarely wait politely for a leadership transition. Mace Consult has named Mario Sawaya president of its Americas business, and the hire reads less like ceremonial executive shuffling than a deliberate move toward the thickest part of the capital-spending map. Sawaya brings more than 20 years of experience leading...

Continue Reading
Birla Carbon's Rayong Bet Tightens Asian Supply Lines

Updated Category News Views 105

Rayong just became a much louder pin on Asia's industrial map. Birla Carbon has inaugurated a 120 kMT carbon black plant in Thailand, and the significance is bigger than a ribbon-cutting photo. This is a capacity-and-location move aimed squarely at the uncomfortable part of industrial supply chains: customers need material when they need it, not after it has spent weeks...

Continue Reading
MFB Bancorp Offering Puts Chicago Bank Conversion First

Updated Category News Views 70

A small Chicago thrift is asking investors to fund a corporate makeover, and the fine print matters more than the $10 sticker price. MFB Bancorp has commenced an offering tied to the planned conversion of Mutual Federal Bancorp, MHC from a mutual holding company structure into a stock holding company. This is not some high-growth bank story with a shiny new branch map. It...

Continue Reading
Alphabet Lawsuit Puts Gemini Delays Under a Microscope

Updated Category News Views 173

July’s twin punches to Alphabet shares were not the sort of wobble investors can casually shrug off. First came a report on July 16 that Google was months behind on Gemini 3.5 Pro, its flagship AI model, after disappointing results from updated training data. Then came the harder financial reality a week later: a much larger 2026 capital-spending plan, negative...

Continue Reading
Gene Editing’s Steady Revenue Engine Is Taking Shape

Updated Category News Views 112

Gene editing is finally starting to look less like a science-fair moonshot and more like a working supply chain. That distinction matters. The latest market estimate puts the global gene editing market at $5.23 billion in 2026 and projects $8.49 billion by 2031, a 10.1% compound annual growth rate. Respectable growth, certainly, but the real investment story is not a...

Continue Reading
IDEMIA Lands Sweden's Critical 5G Connectivity Job

Updated Category News Views 119

A hospital monitor going dark because a device was misprovisioned is not the kind of connectivity hiccup anybody gets to shrug off. That is why IDEMIA Secure Transactions winning the Region Västra Götaland assignment deserves more attention than the usual telecom plumbing announcement. The region is building what it calls Sweden's largest private 5G network, and the job...

Continue Reading
Minno Bets on Listener Kids to Build Premium Growth

Updated Category News Views 131

Children’s media rarely gets a clean strategic move, but this one comes pretty close. Minno has signed a worldwide, multi-year agreement making it the exclusive faith-based streaming home for Listener Kids’ video library, while commissioning 66 new episodes for its own service. For a company trying to build a serious Christian family-media business, that is more than...

Continue Reading
Qiandaohu Whisky Film Puts Craft Before Market Hype

Updated Category News Views 80

Three Distillers, One Very Large Question Whisky does not become world-class because a camera crew found a pretty shoreline. That is the blunt truth sitting underneath this Nov. 19, 2026 documentary release from CCTV+. The film follows three international distillers working at three separate whisky distilleries along Qiandaohu, while also lingering on their day-to-day...

Continue Reading
EmTech AI 2027 Puts AI Ambitions Through Reality Test

Updated Category News Views 111

A three-day gathering cannot settle AI's biggest arguments, but MIT Technology Review has picked the right fight for EmTech AI 2027: make the industry face a Reality Test. The conference runs May 11–13, 2027, at MIT's campus and online, and that theme lands because the AI conversation has spent plenty of time admiring the engine while skipping the ugly maintenance bill....

Continue Reading
Titan Center Lease Gives Pocatello Retail Some Teeth

Updated Category News Views 157

A chicken sandwich lease is not usually a redevelopment thesis, yet Titan Center's new Chick-fil-A deal carries more weight than a routine restaurant announcement. Industrial Realty Group has landed a nationally recognized tenant at the entrance to a property with a long, complicated industrial past. In a smaller market, that sort of win can matter. Retail momentum is...

Continue Reading

Top 5 Most Recently Viewed Articles

TriMas Packaging Unveils Eco-Friendly Foaming Pump Solution

Updated Category News Views 260

TriMas Packaging Launches Sustainable Foaming Pump TriMas Packaging, a leading segment of TriMas (NASDAQ: TRS), recently introduced a groundbreaking addition to its product lineup. This new foaming pump is part of their patented Singolo™ series, showcasing a commitment to sustainability and innovation within the packaging industry. Innovative Design for Enhanced...

Continue Reading
Investing Insights: The Future of Nutex Health Inc. Explained

Updated Category News Views 189

Overview of Nutex Health Inc. Nutex Health Inc. is a company that has garnered significant attention in the healthcare sector. The company specializes in offering healthcare services that incorporate innovative technology to enhance patient care. Known for its commitment to quality, Nutex strives to improve healthcare accessibility and efficiency. Pomerantz Law Firm's...

Continue Reading
Innovative Partnership to Enhance Biosensors in Life Sciences

Updated Category News Views 162

Collaboration between Monod Bio and Gator Bio In an exciting development within the life sciences sector, Monod Bio and Gator Bio have announced a strategic partnership aimed at enhancing the capabilities of biosensors designed for advanced research applications. This collaboration represents a significant step towards innovation in bioanalytical tooling, reflecting both...

Continue Reading
TruGolf Links Welcomes New Franchisee for Growth on Long Island

Updated Category News Views 350

TruGolf Links Expands with New Franchisee TruGolf Links Franchising, LLC, a subsidiary of TruGolf Holdings, Inc. (NASDAQ: TRUG), recently announced an exciting development in its franchise program with the signing of Giovanni 'Gio' Dinsay. With a robust background in physical therapy spanning over 27 years, Gio is recognized as a leader in the wellness industry, having...

Continue Reading
Significant Capital Influx into U.S. Equity Funds: Insights

Updated Category News Views 126

U.S. Equity Funds Experience Remarkable Inflows Recent reports indicate that U.S. equity funds have attracted substantial investments, signaling a strong market interest. This surge in investments can be attributed to impressive third-quarter earnings from major U.S. banks and mounting speculation regarding a possible Federal Reserve rate cut in the near future. In light...

Continue Reading